Erythrocin IV lactobionate 1g powder for solution for infusion vials

Land: Vereinigtes Königreich

Sprache: Englisch

Quelle: MHRA (Medicines & Healthcare Products Regulatory Agency)

Wirkstoff:

Erythromycin lactobionate

Verfügbar ab:

Advanz Pharma

ATC-Code:

J01FA01

INN (Internationale Bezeichnung):

Erythromycin lactobionate

Dosierung:

1gram

Darreichungsform:

Powder for solution for infusion

Verabreichungsweg:

Intravenous

Klasse:

No Controlled Drug Status

Verschreibungstyp:

Valid as a prescribable product

Produktbesonderheiten:

BNF: 05010500; GTIN: 5060064171196

Fachinformation

OBJECT 1
ERYTHROMYCIN LACTOBIONATE 1G POWDER FOR
SOLUTION FOR INFUSION
Summary of Product Characteristics Updated 11-Jan-2018 | Concordia
International - formerly AMCo
1. Name of the medicinal product
Erythrocin I.V. Lactobionate 1g Powder for Solution for Infusion
Erythromycin Lactobionate 1g Powder for Solution for Infusion
2. Qualitative and quantitative composition
Active: Erythromycin as Erythromycin lactobionate 1 g / vial
3. Pharmaceutical form
Powder for solution for infusion
4. Clinical particulars
4.1 Therapeutic indications
This medicine is indicated in severe and immunocompromised cases of
infections caused by sensitive
organisms where high blood levels are required at the earliest
opportunity or when the oral route is
compromised.
1. Upper Respiratory Tract infections: tonsillitis, peritonsillar
abscess, pharyngitis, laryngitis, sinusitis,
secondary infections in influenza and common colds
2. Lower Respiratory Tract infections: tracheitis, acute and chronic
bronchitis, pneumonia (lobar
pneumonia, bronchopneumonia, primary atypical pneumonia),
bronchiectasis, Legionnaire's disease
3. Ear infection: otitis media and otitis externa, mastoiditis
4. Oral infections: gingivitis, Vincent's angina
5. Eye infections: blepharitis
6. Skin and soft tissue infections: boils and carbuncles, paronychia,
abscesses, pustular acne, impetigo,
cellulitis, erysipelas
7. Gastrointestinal infections: cholecystitis, staphylococcal
enterocolitis
8. Prophylaxis: peri-operative secondary infection prophylaxis, severe
trauma and burns secondary
infection prophylaxis, endocarditis prophylaxis (dental procedures)
9. Septicaemia
10. Endocarditis
11. Other infections: osteomyelitis, urethritis, gonorrhoea, syphilis,
lymphogranuloma venereum,
diphtheria, prostatitis, scarlet fever.
4.2 Posology and method of administration
Adults: severe and immunocompromised infections, 50mg/kg/day,
preferably by continuous infusion
(equivalent to 4g per day for adults).
Mild to moderate infections (oral route compromised) 25mg/kg/day.
Newborn infa